Skip to main content
. 2013 Sep 19;8(9):e74780. doi: 10.1371/journal.pone.0074780

Figure 9. Ziprasidone effect on Nile Red fluorescence of C. elegans mutant to the serotoninergic.

Figure 9

(A) Representative images of Nile Red fluorescence on C. elegans wild-type and mutants; (B) Fluorescence profile of Nile Red label on mutants exposed to the vehicle (0.16% DMSO in Acetic acid (1:10 000)) and (C) percentage of loss of Nile Red fluorescence on mutants exposed to Ziprasidone (40µM) compared to the wild-type worm (N2). The treatment began in the L4 larval stage until adult. ##p<0.0001 statistically different compared with wild-type worm exposed to the vehicle; ***p<0.0001 statistically different compared with wild-type worm under Ziprasidone (40µM) treatment (% of control, SD, n> 15, one way ANOVA with Bonferroni correction for post hoc multiple comparisons).